BioLife Solutions (BLFS) Misses Q4 EPS by 20c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $24.90 --0%
EPS Growth %: +109.1%
Financial Fact:
Amortization of deferred financing costs: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +109.1%
Financial Fact:
Amortization of deferred financing costs: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $37.3 million versus the consensus estimate of $35.81 million.
GUIDANCE:
BioLife Solutions sees FY2022 revenue of $159.5-171 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
